NCT07172360

Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

A Multicenter, Randomized, Double-blind, Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of VC005 Tablets in Subjects With Active Ankylosing Spondylitis

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 420 (estimated)
• Sponsor: Jiangsu vcare pharmaceutical technology co., LTD · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study.

Conditions

• Active Ankylosing Spondylitis

Interventions

Type	Name	Description
DRUG	VC005 tablets	VC005 groups repeat administration for 48 weeks
DRUG	VC005 Tablets Placebo	VC005 placebo groups repeat administration for 48 weeks

Timeline

• Start date: 2025-12-26
• Primary completion: 2027-08-30
• Completion: 2027-08-30
• First posted: 2025-09-15
• Last updated: 2026-01-02

Locations

1 site across 1 country: China